Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXL20020294	依达拉酮	edaravone	Active ingredient	Chemical Drugs(2)	New Drug Application	2002-02-23	广东省顺德市顺峰药业有限公司	Guangdong Crshunfeng Pharmaceutical Co Ltd	Certificate Issued	2003-04-18	view
CXL20021680	盐酸尼非卡兰	Nifekalant Hydrochloride	Active ingredient	Chemical Drugs(2)	New Drug Application	2003-08-21	广东省顺德市顺峰药业有限公司	Guangdong Crshunfeng Pharmaceutical Co Ltd	Certificate Issued	2004-01-19	view
CXL20021681	注射用盐酸尼非卡兰	Nifekalant Hydrochloride	Lyophilized	Chemical Drugs(2)	New Drug Application	2003-08-21	广东省顺德市顺峰药业有限公司	Guangdong Crshunfeng Pharmaceutical Co Ltd	Certificate Issued	2004-01-19	view
CXL20020639	氯雷他定糖浆	loratadine	Oral solution	Chemical Drugs(4)	New Drug Application	2002-04-09	广东省顺德市顺峰药业有限公司	Guangdong Crshunfeng Pharmaceutical Co Ltd	Approval Completed-Pending Certificated	2003-03-14	view
CXL20020295	依达拉酮注射液	edaravone	Injection	Chemical Drugs(2)	New Drug Application	2002-02-23	广东省顺德市顺峰药业有限公司	Guangdong Crshunfeng Pharmaceutical Co Ltd	Certificate Issued	2003-04-18	view
CXb20020191	注射用阿奇霉素	azithromycin	Lyophilized	Chemical Drugs(4)	Supplementary Application	2002-04-01	广东省顺德市顺峰药业有限公司	Guangdong Crshunfeng Pharmaceutical Co Ltd	Certificate Issued	2003-03-11	view